What does it do? Folic acid is a B vitamin needed for cell
replication and growth. Folic acid helps form building blocks of DNA, the body’s genetic
information, and building blocks of RNA, needed for protein synthesis in all cells. Therefore,
rapidly growing tissues, such as those of a fetus, and rapidly regenerating cells, like red
blood cells and immune cells, have a high need
for folic acid. Folic acid deficiency results in a form of anemia that responds quickly to
folic acid supplementation.
The requirement for folic acid increases considerably during pregnancy.1 Deficiencies of folic acid during
pregnancy are associated with low birth weight and an increased incidence of neural tube defects in infants.2 In one study,
women who were at high risk of giving birth to babies with neural tube defects were able to
lower their risk by 72% by taking folic acid supplements prior to and during
pregnancy.3 Most doctors, many other healthcare professionals, and the March of
Dimes recommend that all women of childbearing age supplement with 400 mcg per day of folic
acid. Such supplementation would protect against the formation of neural tube defects during
the time between conception and when pregnancy is discovered. If a woman waits until after
pregnancy has been discovered to begin taking folic acid supplements, it will probably be too
late to prevent a neural tube defect.
Other birth defects may be prevented with folic
acid supplementation as well. Women who take folic acid–containing multivitamin supplements around the time they conceive may
also reduce the risk of other congenital malformations, such as heart defects, defects of the upper lip and
mouth,4 urinary tract
defects,5 6 and
limb-reduction defects.7 8 Rates of prevention of cleft lip and cleft
palate may be improved by using very large amounts of folic acid (6 mg per
day).9 A doctor should supervise anyone wishing to take this much folic acid.
Folic acid is needed to keep homocysteine
(an amino acid by-product) levels in blood from rising.
A growing body of evidence suggests that an elevated homocysteine level is a risk factor for
heart disease 10 and may also
be linked to several other diseases. Folic acid and certain other B vitamins function as
cofactors for enzymes that can lower homocysteine levels.
Research has shown that supplementing with folic acid reduces homocysteine
levels.11 Of the B vitamins with a role in homocysteine metabolism, folic acid
appears to be the most important in lowering homocysteine levels for the average
person.12 13 A deficiency of folic acid has also been associated with
peripheral vascular disease and coronary artery disease even in people with normal
homocysteine levels, suggesting that the vitamin may have protective effects that extend
beyond its role in maintaining normal homocysteine levels.14
In 1996, the FDA began to require that all enriched
flour, rice,
pasta, cornmeal, and other grain products contain
140 mcg of folic acid per 100 grams.15 Among people who do not take vitamin supplements, this amount of food
fortification has been associated with increased folic acid levels in the blood and decreased
blood levels of homocysteine.16 Nevertheless, evidence is mounting that the
FDA-mandated level of folic acid fortification in food is inadequate to fully prevent neural
tube defects.17 Until fortification rates are quadrupled, women who can possibly
become pregnant are advised to take a folic acid supplement of 400 mcg per day.
A diet low in folic acid has been associated with a high incidence of pre-cancerous polyps
in the colon, suggesting that folic acid may prevent the development of colon cancer.18 Two studies have shown that
reduced folic acid levels are associated with an increase in the incidence of cancer in people with ulcerative colitis 19 20 and a
third study showed the degree of abnormal cell growth decreases as folic acid intake
increases.21 Three large population studies showed that low folic acid intake is
associated with an increased risk of colorectal cancer.22 23
24
In addition, decreased blood levels of folic acid are associated with an increased risk of
colon cancer in women.25 Long-term supplementation with folic acid from a multivitamin has been found in one large population study to
be associated with a reduced risk of colon cancer. However, 15 years of supplementation was
necessary before a significant reduction in colon-cancer risk became apparent. In that study,
folic acid from dietary sources alone was associated with a modest reduction in the risk of
colon cancer.26
Total folic acid intake was not associated with overall risk of breast cancer in preliminary studies.27
28 However, among women who consume at least one alcoholic beverage per day, the risk of
breast cancer appears to be highest among those with low folic acid intake. Current use of a
multivitamin supplement has also been associated with lower breast cancer risk among women who
consume at least 1.5 alcoholic beverages per day, compared to those who never use a
multivitamin supplement.
Who is likely to be deficient? Many people consume less than
the recommended amount of folic acid. Scientists have found that people with heart disease commonly have elevated blood levels
of homocysteine, a laboratory test abnormality
often controllable with folic acid supplements. This suggests that many people in Western
societies have a mild folic acid deficiency. In fact, it has been suggested that increasing
folic acid intake could prevent an estimated 13,500 deaths from cardiovascular diseases each
year.29
Folic acid deficiency has also been common in
alcoholics, people living at poverty level, those with malabsorption disorders or liver disease (e.g., cirrhosis), and women taking the birth control pill. Recently, elderly people with
hearing loss have been reported to be much more likely to be folic acid deficient than healthy
elderly people.30 A variety of prescription drugs including cimetidine, antacids, some
anticancer drugs, triamterene, sulfasalazine, and
anticonvulsants interfere with folic acid.
Deficiency of folic acid can be precipitated by situations wherein the body requires
greater than normal amounts of the vitamin, such as
pregnancy, infancy, leukemia, exfoliative dermatitis, and diseases that cause the
destruction of blood cells.31
The relationship between folic acid and prevention of neural tube defects is partly thought to result from the
high incidence of folate deficiency in many societies. To protect against neural tube defects,
the U.S. Food and Drug Administration has mandated that some grain products provide
supplemental folic acid at a level expected to increase the dietary intake by an average of
100 mcg per day per person. As a result of folic acid added to the food supply, fewer
Americans will be depleted compared with the past. In 1999, scientific evidence began to
demonstrate that the folic acid added to the U.S. food supply was having positive effects,
including a partial lowering of homocysteine levels.32 In the same year, however, a
report from the North Carolina Birth Defects Monitoring Program suggested the current level of
folic acid fortification has not reduced the incidence of neural-tube defects.33
Many doctors and the Centers for Disease Control in Atlanta34 believe that optimal
levels of folic acid intake may still be higher than the amount now being added to food by
several hundred micrograms per day. A low blood level of folate has also been associated with
an increased risk of miscarriage.35
People with kidney failure have an increased risk of folic acid deficiency.36
Recipients of kidney transplants often have elevated homocysteine levels, which may respond to
supplementation with folic acid.37 The usual recommended amount of 400 mcg per day
may not be enough for these people, however. Larger amounts (up to 2.4 mg per day) may produce
a better outcome, according to one double-blind trial.38
Folate deficiency is more prevalent among elderly African American women than among elderly
white women.39
References:
1. Truswell AS. ABC of nutrition. Nutrition for pregnancy. Br Med
J 1985;291:263–6.
2. Daly LE, Kirke PN, Molloy A, et al. Folate levels and neural tube
defects. JAMA 1995;274:1698–702.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects:
results of the Medical Research Council Vitamin Study. Lancet
1991;338(8760):131–7.
4. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study
of folic acid supplementation during pregnancy. Teratology 1996;53:345–51.
5. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study
of folic acid supplementation during pregnancy. Teratology 1996;53:345–51.
6. Werler MM, Hayes C, Louik C, et al. Multivitamin supplementation and
risk of birth defects. Am J Epidemiol 1999;150:675–82.
7. Shaw GM, O’Malley CD, Wasserman CR, et al. Maternal
periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb
deficiencies among offspring. Am J Med Genet 1995;59:536–45.
8. Werler MM, Hayes C, Louik C, et al. Multivitamin supplementation and
risk of birth defects. Am J Epidemiol 1999;150:675–82.
9. Czeizel AE, Timar L, Sarkozi A. Dose-dependent effect of folic acid on
the prevention of orofacial clefts. Pediatrics 1999;104:e66.
10. Bostom AG, Silbershatz H, Rosenberg IH, et al. Non-fasting plasma
total homocysteine levels and all-cause and cardiovascular disease mortality in elderly
Framingham men and women. Arch Intern Med 1999;159:1077–80.
11. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B12,
vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin
Nutr 1993;57:47–53.
12. Dierkes J, Kroesen M, Pietrzik K. Folic acid and vitamin B6
supplementation and plasma homocysteine concentrations in healthy young women. Int J Vitam
Nutr Res 1998;68:98–103.
13. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic
vascular disease. Arch Intern Med 1998;158:1301–6.
14. Bunout D, Petermann M, Hirsch S, et al. Low serum folate but normal
homocysteine levels in patients with atherosclerotic vascular disease and matched healthy
controls. Nutrition 2000;16:434–8.
15. Food standards: amendment of standards of identity for enriched grain
products to require addition of folic acid. Fed Regist 1996;61:8781–97.
16. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid
fortification on plasma folate and total homocysteine concentrations. N Engl J Med
1999;340:1449–54.
17. Meyer RE, Oakley Jr GP. Folic acid fortification. Lancet
1999;354:2168 [letter].
18. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine,
and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst
1993;85:875–84.
19. Lashner BA, Heidenreich PA, Su GL, et al. Effect of folate
supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A
case-control study. Gastroenterology 1989;97:255–9.
20. Lashner BA. Red blood cell folate is associated with the development
of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol
1993;119:549–54.
21. Lashner BA, Provencher KS, Seidner DL, et al. The effect of folic
acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.
Gastroenterology 1997;112:29–32.
22. Freudenheim JL, Graham S, Marshall JR, et al. Folate intake and
carcinogenesis of the colon and rectum. Int J Epidemiol 1991;20:368–74.
23. Benito E, Stiggelbout A, Bosch FX, et al. Nutritional factors in
colorectal cancer risk: a case-control study in Majorca. Int J Cancer
1991;49:161–7.
24. Meyer F, White E. Alcohol and nutrients in relation to colon cancer
in middle-aged adults. Am J Epidemiol 1993;138:225–36.
25. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate, homocysteine
and colorectal cancer risk in women: a nested case-control study. Br J Cancer
1999;79:1917–21.
26. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use,
folate and colon cancer in women in the Nurse’s Health Study. Ann Intern Med
1998;129:517–24.
27. Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of
folate intake and the risk of breast cancer. JAMA 1999;281:1632–7.
28. Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and
breast cancer risk. J Natl Cancer Inst 2000;92:266–9.
29. Russel RM. A minimum of 13,500 deaths annually from coronary artery
disease could be prevented by increasing folate intake to reduce homocysteine levels.
JAMA 1996;275:1828–9.
30. Houston DK, Johnson MA, Nozza RJ, et al. Age-related hearing loss,
vitamin B-12, and folate in elderly women. Am J Clin Nutr 1999;69:564–71.
31. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency. A
Guide for the primary care physician. Arch Intern Med 1999;159:1289–98
[review].
32. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid
fortification on plasma folate and total homocysteine concentrations. N Engl J Med
1999;340:1449–54.
33. Meyer RE, Oakley GP Jr. Folic acid fortification. Lancet
1999;354:2168 [letter].
34. Oakley GP Jr. Eat right and take a multivitamin. N Engl
J Med 1998;338:1060–1 [editorial].
35. Nelen WL, Blom HJ, Steegers EA, et al. Homocysteine and folate levels
as risk factors for recurrent early pregnancy loss. Obstet Gynecol
2000;95:519–24.
36. Makoff R. Vitamin replacement therapy in renal failure patients.
Miner Electrolyte Metab 1999;25:349–51 [review].
37. Bostom AG, Gohh RY, Beaulieu AJ, et al. Treatment of
hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.
Ann Intern Med 1997;127:1089–92.
38. Beaulieu AJ, Gohh RY, Han H, et al. Enhanced reduction of fasting
total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid
supplementation in renal transplant recipients. Arterioscler Thromb Vasc Biol
1999;19:2918–21.
39. Stabler SP, Allen RH, Fried LP, et al. Racial differences in
prevalence of cobalamin and folate deficiencies in disabled elderly women. Am J Clin
Nutr 1999;70:911–9.
40. Neuhouser ML, Beresford SA, Hickok DE, Monsen ER. Absorption of
dietary and supplemental folate in women with prior pregnancies with neural tube defects and
controls. J Am Coll Nutr 1998;17:625–30.
41. Bailey L. New standard for dietary folate intake in pregnant women.
Am J Clin Nutr 2000;71(Suppl):1304S–7S [review].
42. Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief
review. Am J Clin Nutr 1989;50:353–8.
43. Wald NJ, Bower C. Folic acid, pernicious anaemia, and prevention of
neural tube defects. Lancet 1994;343:307.
44. Russell RM, Dutta SK, Oaks EV, et al. Impairment of folic acid
absorption by oral pancreatic extracts. Dig Dis Sci 1980;25:369–73.